Evidence map›Paper›PMID 34522844›Full record

ArticleHemaSphere2021

The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies.

Hermann Einsele, Javier Briones, Fabio Ciceri, Irene García Cadenas, Fred Falkenburg, Natacha Bolaños, H M Mirjam Heemskerk, Roch Houot, Michael Hudecek, Franco Locatelli and 6 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Hermann EinseleDepartment of Internal Medicine II, University Hospital Würzburg, Germany.
Javier BrionesHematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Fabio CiceriDepartment Hematology and BMT Unit, San Raffaele Scientific Institute, Milano, Italy.
Irene García CadenasHematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Fred FalkenburgDepartment of Hematology, Leiden University Medical Center, The Netherlands.
Natacha BolañosLymphoma Coalition Europe, Paris, France.
H M Mirjam HeemskerkDepartment of Hematology, Leiden University Medical Center, The Netherlands.
Roch HouotCHU Rennes, University of Rennes, INSERM U1236, France.
Michael HudecekDepartment of Internal Medicine II, University Hospital Würzburg, Germany.
Franco LocatelliLa Sapienza, University of Rome, Italy.
Kate MorganMyeloma Patients Europe, Brussels, Belgium.
Emma C MorrisUniversity College London, United Kingdom.
Michael O'DwyerNational University of Ireland, Galway, Ireland.
Jordi Gil SierraHematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Marcel van den BrinkMemorial Sloan-Kettering Cancer Center and Sloan Kettering Institute, New York, NY, USA.
Arjan A van de LoosdrechtAmsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, The Netherlands.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34522844
PMCPMC8432635

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.